The American College of Cardiology (ACC), the American Heart Association and nine other leading medical associations, today issued an updated guideline for the management of dyslipidemia—abnormal ...
The U.S. Department of Health and Human Services (HHS) and U.S. Department of Agriculture have released new Dietary Guidelines for Americans intended to guide federal nutrition policy for the next ...
Chronic consumption of high levels of caffeine a day can lead to an increase in high heart rate and blood pressure that persists after resting from a step test, increasing the risk of cardiovascular ...
Global death counts due to cardiovascular disease (CVD) increased from 12.4 million in 1990 to 19.8 million in 2022, reflecting global population growth and aging and the contributions from ...
The Centers for Medicare and Medicaid Services (CMS) has issued the 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule. CMS has ...
The Centers for Medicare and Medicaid Services (CMS) has proposed a change in methodology to indirect practice expense (PE) payment in the proposed 2026 Medicare Physician Fee Schedule (PFS), which ...
Helping to shepherd the College further into the AI era with the creation of an AI implementation Task Force and the beginning of a relationship with Open Evidence. Advocacy! The College showed ...
The U.S. Food and Drug Administration (FDA) has approved the FARAPULSE Pulsed Field Ablation System for isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, ...
TRANSFORMING CARDIOVASCULAR CARE FOR ALL STARTS HERE! Join the American College of Cardiology (ACC) and the Korean Society of Cardiology for ACC Asia 2026 Together With KSC Spring Conference. Designed ...
The U.S. Food and Drug Administration (FDA) has approved Cardamyst™ (etripamil) nasal spray to treat adults with paroxysmal supraventricular tachycardia (PSVT). This rapid-acting, self-administered ...
Cardiovascular clinicians can bill new or revised codes for PCI, lower extremity revascularization (LER), coronary plaque analysis and other services starting Jan. 1, 2026. The ACC Advocacy team has ...
A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure (SBP) by between ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results